Connection

Co-Authors

This is a "connection" page, showing publications co-authored by HAGOP M KANTARJIAN and YU SHEN.
Connection Strength

0.317
  1. Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System. Leuk Lymphoma. 2007 Jun; 48(6):1150-60.
    View in: PubMed
    Score: 0.074
  2. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Cancer. 2003 Jan 15; 97(2):450-6.
    View in: PubMed
    Score: 0.055
  3. High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia. Cancer. 2001 Jul 01; 92(1):7-14.
    View in: PubMed
    Score: 0.049
  4. Prognostic significance of monocytosis in patients with myeloproliferative disorders. Leuk Lymphoma. 2006 Mar; 47(3):417-23.
    View in: PubMed
    Score: 0.017
  5. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. Leukemia. 2005 Sep; 19(9):1567-72.
    View in: PubMed
    Score: 0.016
  6. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer. 2004 May 01; 100(9):1884-91.
    View in: PubMed
    Score: 0.015
  7. C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leuk Res. 2004 Apr; 28(4):373-8.
    View in: PubMed
    Score: 0.015
  8. Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. Leukemia. 2003 May; 17(5):990-3.
    View in: PubMed
    Score: 0.014
  9. Myelodysplastic syndrome is not merely "preleukemia". Blood. 2002 Aug 01; 100(3):791-8.
    View in: PubMed
    Score: 0.013
  10. Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome. Cancer. 2002 Jan 01; 94(1):14-7.
    View in: PubMed
    Score: 0.013
  11. High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens. Cancer. 2001 Oct 15; 92(8):1999-2015.
    View in: PubMed
    Score: 0.013
  12. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival. Leuk Lymphoma. 2001 Jun; 42(1-2):67-73.
    View in: PubMed
    Score: 0.012
  13. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998 Apr; 4(4):861-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.